Search for: "Novartis Corporation " Results 81 - 100 of 314
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Aug 2012, 7:04 pm
In this case, Novartis Pharmaceuticals Corporation sales representatives in 2006 claim that they were denied overtime pay which is a violation of the Fair Labor Standards Act. [read post]
18 Feb 2009, 12:47 pm
Sales representatives of Novartis Pharmaceutical Corporation who brought a class action have been determined to be exempt employees under the Fair Labor Standards Act, thus bringing an abrupt end (for the plaintiffs) to the litigation. [read post]
23 Aug 2011, 2:46 pm by Lawrence B. Ebert
Genetics points out that the outcome of this § 291 action “will have real-world consequences,” because Genetics’ corporate parent, Wyeth, has been sued for allegedly infringing the Novartis patents in a related case in the United States District Court for the Eastern District of Texas. [read post]
30 Jun 2014, 4:23 am by Lawrence B. Ebert
Milliken & Company Northrop Grumman Corporation Novartis Patent Café.com, Inc. [read post]
16 Apr 2009, 10:01 pm
The article notes the an anti-business coverage in the news media and a backlash by juries, citing a February verdict against Novartis in Alabama—a notorious pro-corporate state—for $78.4 million, including $50 million in punitive damages, for overcharging Medicare for prescription drugs. [read post]
10 Jul 2020, 10:39 am by Patrick A. Malone
Big Pharma focuses relentlessly on always making a buck, no matter the cost to the rest of us, and even a viral pandemic that infects 2.8 million Americans and kills roughly 130,000 of us won’t interrupt the corporate rapaciousness. [read post]
5 Sep 2013, 1:49 pm by Ray Dowd
 Lewis VP of Tax & Insurance Novartis CorporationKaren Milhoua Director - Transfer Pricing IBM Corporation Stanley Sherwood International Tax Counsel KERINGModerator: Brian Power Senior Associate Mayer Brown LLP8:00 a.m. [read post]
15 Sep 2015, 2:20 pm by Tom Lamb
This September 2015 Drug Safety Alert Is Based Primarily On Reports Of Skin Cancer And Lymphoma Blood Cancer &nbsp (Posted by Tom Lamb at DrugInjuryWatch.com)   Health Canada recently conducted a review of safety information obtained from the drug company Novartis Pharmaceuticals Corporation, the manufacturer of Gilenya (fingolimod), about a potential link between the use of this multiple sclerosis (MS) drug and certain types of cancers and malignant tumors or neoplasms. [read post]
6 Aug 2015, 2:08 pm by Tom Lamb
We will continue to monitor the safety profile of Gilenya as regards PML and the other serious side effects this Novartis MS drug has been associated with in recent years. [read post]
17 May 2010, 7:02 am by randal shaheen
A pop-up disclaimer for this third website -- you are “moving to an external website independently operated and not managed by the Novartis Pharmaceuticals Corporation” -- did nothing to dispel FDA’s belief that Novartis was responsible for its content. [read post]